Xiaoyang Zhao

Dr. Xiaoyang Zhao


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2009 in Nature
Verified
Journal Article
Closed access
XZXiaoyang Zhao
Xiaoyang Zhao
WLWei Li
Wei Li
ZLZhuo Lv
Zhuo Lv
LLLei Liu
Lei Liu
MTMan Tong
Man Tong
QZQi Zhou
Qi Zhou

1 October 2018 in Cell Stem Cell
Verified
Journal Article
Closed access
MWMei Wang
Mei Wang
XLXixi Liu
Xixi Liu
GCGang Chang
Gang Chang
YCYidong Chen
Yidong Chen
GAGeng An
Geng An
JQJie Qiao
Jie Qiao

1 March 2016 in Cell Stem Cell
Verified
Journal Article
Closed access
QZQuan Zhou
Quan Zhou
MWMei Wang
Mei Wang
YYyan yuan
yan yuan
XWXuepeng Wang
Xuepeng Wang
RFRui Fu
Rui Fu
QZQi Zhou
Qi Zhou

31 July 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
YZyang zhang
yang zhang
TLTianyuan Liu
Tianyuan Liu
XHXuesong Hu
Xuesong Hu
MWMei Wang
Mei Wang
JWJing Wang
Jing Wang
XZXiaoyang Zhao
Xiaoyang Zhao
With the dramatic development of single-cell RNA sequencing (scRNA-seq) technologies, the systematic decoding of cell-cell communication has received great research interest. To date, several in-silico methods have been developed, but most of them lack the ability to predict the communication pathways connecting the insides and outsides of cells. Here, we developed CellCall, a toolkit to infer inter- and intracellular communication pathways by integrating paired ligand-receptor and transcription factor (TF) activity. Moreover, CellCall uses an embedded pathway activity analysis method to identify the significantly activated pathways involved in intercellular crosstalk between certain cell types. Additionally, CellCall offers a rich suite of visualization options (Circos plot, Sankey plot, bubble plot, ridge plot, etc.) to present the analysis results. Case studies on scRNA-seq datasets of human testicular cells and the tumor immune microenvironment demonstrated the reliable and unique functionality of CellCall in intercellular communication analysis and internal TF activity exploration, which were further validated experimentally. Comparative analysis of CellCall and other tools indicated that CellCall was more accurate and offered more functions. In summary, CellCall provides a sophisticated and practical tool allowing researchers to decipher intercellular communication and related internal regulatory signals based on scRNA-seq data. CellCall is freely available at https://github.com/ShellyCoder/cellcall.

1 June 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LLLei Liu
Lei Liu
GLGuan-Zheng Luo
Guan-Zheng Luo
WYWei Yang
Wei Yang
XZXiaoyang Zhao
Xiaoyang Zhao
QZQinyuan Zheng
Qinyuan Zheng
QZQi Zhou
Qi Zhou
Low reprogramming efficiency and reduced pluripotency have been the two major obstacles in induced pluripotent stem (iPS) cell research. An effective and quick method to assess the pluripotency levels of iPS cells at early stages would significantly increase the success rate of iPS cell generation and promote its applications. We have identified a conserved imprinted region of the mouse genome, the Dlk1-Dio3 region, which was activated in fully pluripotent mouse stem cells but repressed in partially pluripotent cells. The degree of activation of this region was positively correlated with the pluripotency levels of stem cells. A mammalian conserved cluster of microRNAs encoded by this region exhibited significant expression differences between full and partial pluripotent stem cells. Several microRNAs from this cluster potentially target components of the polycomb repressive complex 2 (PRC2) and may form a feedback regulatory loop resulting in the expression of all genes and non-coding RNAs encoded by this region in full pluripotent stem cells. No other genomic regions were found to exhibit such clear expression changes between cell lines with different pluripotency levels; therefore, the Dlk1-Dio3 region may serve as a marker to identify fully pluripotent iPS or embryonic stem cells from partial pluripotent cells. These findings also provide a step forward toward understanding the operating mechanisms during reprogramming to produce iPS cells and can potentially promote the application of iPS cells in regenerative medicine and cancer therapy.

6 December 2011 in Cell Research
Verified
Journal Article
Closed access
NCNan Cao
Nan Cao
ZLZumei Liu
Zumei Liu
ZCZhongyan Chen
Zhongyan Chen
JWJia Wang
Jia Wang
TCTaotao Chen
Taotao Chen
HYHuang-Tian Yang
Huang-Tian Yang